449 results on '"Cai, Weijing"'
Search Results
2. Inhibition of cotranslational translocation by apratoxin S4: Effects on oncogenic receptor tyrosine kinases and the fate of transmembrane proteins produced in the cytoplasm
3. Concomitant EGFR Mutation and EML4-ALK Rearrangement in Lung Adenocarcinoma Is More Frequent in Multifocal Lesions
4. In vitro formation of Maillard reaction products during simulated digestion of meal-resembling systems
5. Epigenetic regulation of RCAN1 expression in kidney disease and its role in podocyte injury
6. A Phase II Clinical Trial of Apatinib in Pretreated Advanced Non-squamous Non–small-cell Lung Cancer
7. EGFR-TKIs plus chemotherapy demonstrated superior efficacy than EGFR-TKIs alone as first-line setting in advanced NSCLC patients with EGFR mutation and BIM deletion polymorphism
8. Discovery of new A- and B-type laxaphycins with synergistic anticancer activity
9. Development of apratoxin S10 (Apra S10) as an anti-pancreatic cancer agent and its preliminary evaluation in an orthotopic patient-derived xenograft (PDX) model
10. Advanced Glycation Endproduct (AGE) Receptor 1 Is a Negative Regulator of the Inflammatory Response to AGE in Mesangial Cells
11. Clonality Analysis for the Relationship between the Pulmonary Combined Neuroendocrine Carcinoma and “the So-Called Reported Histologic Transformation”
12. Retinoic acid improves nephrotoxic serum–induced glomerulonephritis through activation of podocyte retinoic acid receptor α
13. Characterization of Liver Metastasis and Its Effect on Targeted Therapy in EGFR-mutant NSCLC: A Multicenter Study
14. Comprehensive Analysis of EGFR-Mutant Abundance and Its Effect on Efficacy of EGFR TKIs in Advanced NSCLC with EGFR Mutations
15. Inflammatory Mediators Are Induced by Dietary Glycotoxins, a Major Risk Factor for Diabetic Angiopathy
16. Immunogenicity of Del19 EGFR mutations in Chinese patients affected by lung adenocarcinoma
17. Prognostic impact of tumor mutation burden and the mutation in KIAA1211 in small cell lung cancer
18. Molecular genetic characteristics of thymic epithelial tumors with distinct histological subtypes
19. AIMedGraph: a comprehensive multi-relational knowledge graph for precision medicine
20. An innovative single‐base extension method for synchronous detection of point mutations and MSI status in colorectal cancer
21. Peripheral Blood for Epidermal Growth Factor Receptor Mutation Detection in Non-Small Cell Lung Cancer Patients
22. Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans
23. MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design
24. Publisher Correction: Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes
25. Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial
26. A Retrospective Study in Adults with Metabolic Syndrome: Diabetic Risk Factor Response to Daily Consumption of Agaricus bisporus (White Button Mushrooms)
27. Impact of family history of cancer on the incidence of mutation in epidermal growth factor receptor gene in non-small cell lung cancer patients
28. Effects of a whole rice diet on metabolic parameters and inflammatory markers in prediabetes
29. Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1
30. Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer
31. Publisher Correction: Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes
32. Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes
33. A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer
34. Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals
35. Advanced Glycation End Product (AGE) Receptor 1 Suppresses Cell Oxidant Stress and Activation Signaling via EGF Receptor
36. An innovative single‐base extension method for synchronous detection of point mutations and MSI status in colorectal cancer.
37. Advanced Glycation End Products in Foods and a Practical Guide to Their Reduction in the Diet
38. A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer
39. Multi‐omics analysis of intra‐tumoural and inter‐tumoural heterogeneity in pancreatic ductal adenocarcinoma
40. Elevated Serum Advanced Glycation Endproducts in Obese Indicate Risk for the Metabolic Syndrome: A Link Between Healthy and Unhealthy Obesity?
41. Suppression of native defense mechanisms, SIRT1 and PPARγ, by dietary glycoxidants precedes disease in adult humans; relevance to lifestyle-engendered chronic diseases
42. Identifying Advanced Glycation End Products as a Major Source of Oxidants in Aging: Implications for the Management and/or Prevention of Reduced Renal Function in Elderly Persons
43. Advanced Glycation End Product Receptor-1 Transgenic Mice Are Resistant to Inflammation, Oxidative Stress, and Post-Injury Intimal Hyperplasia
44. Identifying prognostic signatures in the microenvironment of prostate cancer
45. Restriction of Dietary Advanced Glycation End Products Induces a Differential Plasma Metabolome and Lipidome Profile
46. Oral Glycotoxins Determine the Effects of Calorie Restriction on Oxidant Stress, Age-Related Diseases, and Lifespan
47. AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-[delta]: implications for vascular disease
48. The Bim deletion polymorphism clinical profile and its relation with tyrosine kinase inhibitor resistance in Chinese patients with non–small cell lung cancer
49. Coexistence of Three Variants Involving Two Different Fusion Partners of ROS1 Including a Novel Variant of ROS1 Fusions in Lung Adenocarcinoma: A Case Report
50. Effect of Advanced Glycation End Products on Cognition in Older Adults with Type 2 Diabetes: Results from a Pilot Clinical Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.